Palmer Biff F, Clegg Deborah J
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Biomedical Research Department, Diabetes and Obesity Research Division, Cedars-Sinai Medical Center, Beverly Hills, CA, USA.
Mol Cell Endocrinol. 2015 Feb 15;402:113-9. doi: 10.1016/j.mce.2014.11.029. Epub 2015 Jan 8.
The NIH has recently highlighted the importance of sexual dimorphisms and has mandated inclusion of both sexes in clinical trials and basic research. In this review we highlight new and novel ways sex hormones influence body adiposity and the metabolic syndrome. Understanding how and why metabolic processes differ by sex will enable clinicians to target and personalize therapies based on gender. Adipose tissue function and deposition differ by sex. Females differ with respect to distribution of adipose tissues, males tend to accrue more visceral fat, leading to the classic android body shape which has been highly correlated to increased cardiovascular risk; whereas females accrue more fat in the subcutaneous depot prior to menopause, a feature which affords protection from the negative consequences associated with obesity and the metabolic syndrome. After menopause, fat deposition and accrual shift to favor the visceral depot. This shift is accompanied by a parallel increase in metabolic risk reminiscent to that seen in men. A full understanding of the physiology behind why, and by what mechanisms, adipose tissues accumulate in specific depots and how these depots differ metabolically by sex is important in efforts of prevention of obesity and chronic disease. Estrogens, directly or through activation of their receptors on adipocytes and in adipose tissues, facilitate adipose tissue deposition and function. Evidence suggests that estrogens augment the sympathetic tone differentially to the adipose tissue depots favoring lipid accumulation in the subcutaneous depot in women and visceral fat deposition in men. At the level of adipocyte function, estrogens and their receptors influence the expandability of fat cells enhancing the expandability in the subcutaneous depot and inhibiting it in the visceral depot. Sex hormones clearly influence adipose tissue function and deposition, determining how to capture and utilize their function in a time of caloric surfeit, requires more information. The key will be harnessing the beneficial effects of sex hormones in such a way as to provide 'healthy' adiposity.
美国国立卫生研究院(NIH)最近强调了性别差异的重要性,并要求在临床试验和基础研究中纳入两性。在本综述中,我们重点介绍性激素影响身体肥胖和代谢综合征的新方法。了解代谢过程如何以及为何因性别而异,将使临床医生能够根据性别制定针对性和个性化的治疗方案。脂肪组织的功能和沉积存在性别差异。女性在脂肪组织分布方面有所不同,男性往往会积累更多的内脏脂肪,导致典型的苹果型身材,这与心血管疾病风险增加高度相关;而女性在绝经前皮下脂肪储存中积累更多脂肪,这一特征可保护她们免受肥胖和代谢综合征相关负面影响。绝经后,脂肪沉积和积累转向有利于内脏储存。这种转变伴随着代谢风险的平行增加,类似于男性的情况。全面了解脂肪组织为何以及通过何种机制在特定储存部位积累,以及这些储存在代谢上如何因性别而异的生理机制,对于预防肥胖和慢性病至关重要。雌激素直接或通过激活其在脂肪细胞和脂肪组织中的受体,促进脂肪组织的沉积和功能。有证据表明,雌激素对脂肪组织储存部位的交感神经张力有不同影响,有利于女性皮下储存部位的脂质积累和男性内脏脂肪沉积。在脂肪细胞功能水平上,雌激素及其受体影响脂肪细胞的扩张能力,增强皮下储存部位的扩张能力并抑制内脏储存部位的扩张能力。性激素显然会影响脂肪组织的功能和沉积,要确定如何在热量过剩时捕捉和利用其功能,还需要更多信息。关键在于以提供“健康”肥胖的方式利用性激素的有益作用。